69 related articles for article (PubMed ID: 19950709)
1. [Comparison of therapeutic effects of chemotherapy combined with radiotherapy versus chemotherapy alone in initial treatment of advanced gastric adenocarcinoma].
Zhang Y; Yu YH; Yu JM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):557-8. PubMed ID: 19950709
[No Abstract] [Full Text] [Related]
2. [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].
Dong NN; Wang MY; Zhang Q; Liu ZF
Ai Zheng; 2009 Apr; 28(4):412-5. PubMed ID: 19622303
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
Ke QH; Zhou SQ; Su XY; Liu Z; Zhang WT; Yang JY
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):629-31. PubMed ID: 22325227
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.
Park KW; Ahn JS; Park YS; Lee J; Kang JH; Park JO; Lim HY; Im YH; Kang WK; Park K; Lee SI
Cancer Chemother Pharmacol; 2007 Jan; 59(1):17-21. PubMed ID: 16721549
[TBL] [Abstract][Full Text] [Related]
5. [Epirubicin combined with DDP and 5-Fu for treatment of advanced gastric cancer].
Lu M; Shen L; Li J; Li Y; Zhang XD
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):392-5. PubMed ID: 19799092
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemoradiation for gastric cancer using epirubicin, cisplatin, and 5-fluorouracil before and after three-dimensional conformal radiotherapy with concurrent infusional 5-fluorouracil: a multicenter study of the Trans-Tasman Radiation Oncology Group.
Leong T; Joon DL; Willis D; Jayamoham J; Spry N; Harvey J; Di Iulio J; Milner A; Mann GB; Michael M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):690-5. PubMed ID: 20472363
[TBL] [Abstract][Full Text] [Related]
7. [Short-term effects of chemotherapy with combination of hydroxycamptothecine and oxaliplatin in the treatment of advanced digestive tract cancers].
Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Yao Y
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):749-52. PubMed ID: 15733397
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: a randomized phase II study.
Thuss-Patience PC; Kretzschmar A; Repp M; Kingreen D; Hennesser D; Micheel S; Pink D; Scholz C; Dörken B; Reichardt P
J Clin Oncol; 2005 Jan; 23(3):494-501. PubMed ID: 15659494
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy with FOLFOX: improved outcomes in Chinese patients with locally advanced gastric cancer.
Li ZY; Koh CE; Bu ZD; Wu AW; Zhang LH; Wu XJ; Wu Q; Zong XL; Ren H; Tang L; Zhang XP; Li JY; Hu Y; Shen L; Ji JF
J Surg Oncol; 2012 Jun; 105(8):793-9. PubMed ID: 22189752
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemoradiotherapy with or without intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma.
Zhang Q; Tey J; Peng L; Yang Z; Xiong F; Jiang R; Liu T; Fu S; Lu JJ
Radiother Oncol; 2012 Jan; 102(1):51-5. PubMed ID: 22178689
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
Chakravarty T; Crane CH; Ajani JA; Mansfield PF; Briere TM; Beddar AS; Mok H; Reed VK; Krishnan S; Delclos ME; Das P
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):581-6. PubMed ID: 22137021
[TBL] [Abstract][Full Text] [Related]
12. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.
Amini A; Sanati H
Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy.
Fujitani K; Tsujinaka T; Yamasaki H; Hirao M; Yoshida K; Kurokawa Y
Anticancer Res; 2009 Aug; 29(8):3385-91. PubMed ID: 19661361
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction.
Malik I; Bernal P; Byrd J
Cancer Invest; 2010 Oct; 28(8):833-8. PubMed ID: 20839949
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of outcomes of Taxol + Cisplatin and Taxol + Nedaplatin chemotherapy regimens for advanced non-small cell lung cancer].
Cai YP; Xu S; Lin SJ
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):74-5. PubMed ID: 20211076
[No Abstract] [Full Text] [Related]
18. [Weekly regimen of paclitaxel liposome combined with cisplatin and 5-fluorouracil continuous infusion in the treatment of advanced gastric carcinoma].
Li JH; Li B; Jiang HR; Zhong MZ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):229-31. PubMed ID: 21575526
[TBL] [Abstract][Full Text] [Related]
19. No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer.
Chen S; Chen YB; Zhou ZW; Li W; Sun XW; Xu DZ; Li YF; Guan YX; Feng XY; Zhan YQ
Am J Clin Oncol; 2011 Jun; 34(3):309-13. PubMed ID: 20838324
[TBL] [Abstract][Full Text] [Related]
20. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]